HIF1A and Hepatic fibrosis: Herein, the present study demonstrated that YC-1 administration improved liver fibrosis in mice, which was caused by a BDL through, at least in part decrease of HIF-1α-induced inflammatory cells infiltration, angiogenesis and bile duct epithelial cell proliferation.